208 related articles for article (PubMed ID: 2427760)
21. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
[TBL] [Abstract][Full Text] [Related]
22. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.
Yamauchi J; Takeda K; Shibuya K; Sunamura M; Matsuno S
Pancreatology; 2001; 1(6):662-7. PubMed ID: 12120251
[TBL] [Abstract][Full Text] [Related]
23. Effect of FUT-175 (nafamstat mesilate) on platelets in canine acute experimental pancreatitis.
Gabryelewicz A; Prokopowicz J; Bodzenta A; Bielecki W; Rydzewska G
Digestion; 1988; 40(1):19-24. PubMed ID: 3234615
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of nafamostat mesilate (FUT-175) on O2- production in rat polymorphonuclear leucocytes].
Oda M; Ogihara M; Sato T; Kurumi M; Iwaki M
Nihon Yakurigaku Zasshi; 1986 May; 87(5):521-6. PubMed ID: 3015753
[TBL] [Abstract][Full Text] [Related]
25. [Molecular specificity of nafamostat mesilate (FUT), a drug used for the treatments of DIC and acute pancreatitis and as an anticoagulant--the pharmacodynamics and pharmacological action].
Tsukagoshi S
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1237-43. PubMed ID: 11579633
[TBL] [Abstract][Full Text] [Related]
26. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different treatment modalities in experimental pancreatitis in rats.
Kimura W; Meyer F; Hess D; Kirchner T; Fischbach W; Mössner J
Gastroenterology; 1992 Dec; 103(6):1916-24. PubMed ID: 1451985
[TBL] [Abstract][Full Text] [Related]
28. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
29. Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.
Satake K; Ha S; Hiura A; Nishiwaki H; Haku A; Umeyama K
Gastroenterol Jpn; 1990 Dec; 25(6):720-6. PubMed ID: 2279634
[TBL] [Abstract][Full Text] [Related]
30. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat.
Ono H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Kiriyama S; Sobajima H
Dig Dis Sci; 1990 Jun; 35(6):787-92. PubMed ID: 2344814
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Naruse S; Wang Y; Kitagawa M; Ishiguro H; Seki Y; Ozaki T; Hayakawa T
Pancreas; 2000 Oct; 21(3):290-5. PubMed ID: 11039474
[TBL] [Abstract][Full Text] [Related]
32. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Gao HJ; Song Q; Lv FQ; Wang S; Wang YR; Luo YK; Mei XG; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):707-711. PubMed ID: 26489626
[TBL] [Abstract][Full Text] [Related]
33. [The Pancreas Study Group: Inhibition of pancreas secretion and trypsin activity. Mechanisms and importance of therapy of acute and chronic pancreatitis].
Z Gastroenterol Verh; 1987 Apr; 22():132-55. PubMed ID: 2442904
[No Abstract] [Full Text] [Related]
34. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
[TBL] [Abstract][Full Text] [Related]
35. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro].
Nakamura K; Johmura A; Oda M; Ino Y; Uchiyama H; Ohtani H; Miyazaki H; Kurumi M; Akizawa Y; Oka T
Yakugaku Zasshi; 1995 Mar; 115(3):201-12. PubMed ID: 7738778
[TBL] [Abstract][Full Text] [Related]
37. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis.
Mikami Y; Takeda K; Matsuda K; Qiu-Feng H; Fukuyama S; Egawa S; Sunamura M; Matsuno S
Pancreas; 2005 Apr; 30(3):248-53. PubMed ID: 15782103
[TBL] [Abstract][Full Text] [Related]
38. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
Hirano T; Manabe T; Tobe T
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
[TBL] [Abstract][Full Text] [Related]
39. Protease-antiprotease interactions and the rationale for therapeutic protease inhibitors.
Schmid S; Uhl W; Büchler MW
Scand J Gastroenterol Suppl; 1996; 219():47-50. PubMed ID: 8865472
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
